$71.02
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Country

US

CEO

Mr. Albert White

IPO date

1983

Employees

15,000

ISIN

US2166485019

Key stats

Open

$69.59

Volume

2.63M

Market cap

$13.58B

Prev. close

$71.02

Impl / hst vl

-

Open interest

$0.00

$69.39

Day’s Range

$74.00

$58.89

52W Range

$85.04

Valuation

38
Valuation score
Overvalued
P/E
57.94
P/S
3.23
P/B
1.66
Current ratio
1.27
Debt / Equity
0.28
ROE
2.84%
Gross margin
68.00%
Income growth
-159.56%
FCF growth
-39.26

Aug

11

Dividends

The last payment date was Aug 11, 2023

Div. per Share

$0.03

Div. Yield

0.04%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 10 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$83.05
The top 19 analysts forecasts that 12-month price may increase by 16.94%, with a low of $66.66 and a high of $96.60
$66.66
Low
$83.05
Avg
$96.60
High
Current price

Earnings

Q2 ‘26 revenue
$1.08B
Q2 ‘26 net income
-$77.90M
Revenue
Net income
Previous EPS
$1.21
Estimate EPS
$1.13
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply